ABVC BioPharma (ABVC) vs TransCode Therapeutics (RNAZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ABVC BioPharma (ABVC) has outperformed TransCode Therapeutics (RNAZ) over the past year, losing 68.9% versus a loss of 85.6%. Over five years, ABVC leads with a -96.3% price change compared with -100.0% for RNAZ. TransCode Therapeutics is the larger company by market cap ($29.5 million vs $27.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABVC | RNAZ |
|---|---|---|
| Share price | $1.01 | $1.74 |
| Market cap | $26.96M | $29.46M |
| 1-day change | +1.00% | -1.14% |
| YTD return | -53.05% | -74.23% |
| 1-year return | -68.94% | -85.60% |
| 5-year return | -96.31% | -100.00% |
| EPS (TTM) | $-0.30 | $-52.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.33 | $15.94 |
| 52-week low | $0.707 | $1.52 |
| Distance from 52-week high | -69.67% | -89.08% |
| Average volume | 118.80K | 50.80K |
| Shares outstanding | 26.69M | 16.93M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ABVC has outperformed RNAZ by 16.7 percentage points over the past year.
ABVC vs RNAZ FAQ
Which is bigger, ABVC BioPharma or TransCode Therapeutics?
TransCode Therapeutics (RNAZ) is larger, with a market capitalization of $29.46M compared with $26.96M for ABVC BioPharma (ABVC).
Which stock has performed better over the past year, ABVC or RNAZ?
ABVC returned -68.94% over the past 12 months, compared with -85.60% for RNAZ (price return, excluding dividends). Past performance does not predict future results.
Are ABVC BioPharma and TransCode Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.